MediWound Newsroom

MediWound's (NASDAQ:MDWD) Investors Will Be Pleased With Their Stellar 125% Return Over the Last Year

Yahoo FinanceOct 27 21:17

Rosalind Advisors, Inc. Increases Stake in MediWound Ltd

Yahoo FinanceOct 24 07:01

H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $28

Futu NewsOct 11 18:31 · Ratings

MediWound Price Target Maintained With a $28.00/Share by HC Wainwright & Co.

Dow JonesOct 11 18:21 · Ratings

HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target

BenzingaOct 11 18:11 · Ratings

MediWound Analyst Ratings

BenzingaOct 11 18:08 · Ratings

Express News | Mediwound Ltd - Key Safety Endpoints Include Adverse Events and Wound Closure Time

BreakingsOct 10 19:02

Express News | Mediwound Ltd - to Initiate Phase II Study for Escharex in 2025

BreakingsOct 10 19:02

Express News | Mediwound Announces Phase II Head-to-Head Study Evaluating Escharex® Vs. Collagenase in Patients With Venous Leg Ulcers

BreakingsOct 10 19:00

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx Vs. Collagenase in Patients With Venous Leg Ulcers

MediwoundOct 10 12:00

MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit

Yahoo FinanceOct 8 20:00

MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Yahoo FinanceSep 3 20:00

Express News | Mediwound Ltd Files for Resale of up to 1.45 Mln Ordinary Shares by Selling Shareholders - SEC Filing

BreakingsAug 30 04:46

Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Announces Target Price $30

Maxim Group analyst Michael Okunewitch maintains $MediWound(MDWD.US)$ with a buy rating, and sets the target price at $30.According to TipRanks data, the analyst has a success rate of 31.2% and a

Futu NewsAug 22 02:31 · Ratings

Mediwound Poised for Growth: Buy Rating Backed by NexoBrid Expansion and EscharEx Market Potential

TipRanksAug 22 02:25 · Ratings

MediWound Ltd.'s (NASDAQ:MDWD) Top Owners Are Retail Investors With 38% Stake, While 28% Is Held by Institutions

Yahoo FinanceAug 21 18:25

MediWound Receives Pediatric Indication for Burn Treatment NexoBrid

Seeking AlphaAug 19 00:49

MediWound and Vericel Win FDA Paediatric Label Expansion for NexoBrid

Yahoo FinanceAug 16 22:33

MediWound Gets FDA Approval for Severe Thermal Burn Treatment for Pediatric Patients

MT NewswiresAug 16 15:23

Express News | Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns

BreakingsAug 16 04:15